ANVS Annovis Bio gains 152 percent on investor optimism despite posting a wider than expected Q4 2025 loss Goldman Sachs Group Inc GS Adjusts Treasury Coupon Issuance Forecast Amid Upcoming Q2 Refunding Statement Scrutiny ZNTL Zentalis Pharmaceuticals reports narrower than expected Q4 2025 loss as shares climb 231 percent in todays trading Schwab US REIT ETF SCHH Poised for Cyclical Upside as US 30Year Mortgage Rates Fall Below 6 Threshold